In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Charles River Laboratories International Inc (NYSE: CRL) closed at $106.60 up 6.87% from its previous closing price of $99.75. In other words, the price has increased by $6.87 from its previous closing price. On the day, 3.99 million shares were traded.
Ratios:
For a deeper understanding of Charles River Laboratories International Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.44. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.80 whereas as Long-Term Debt/Eq ratio is at 0.79.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on March 21, 2025, Downgraded its rating to Neutral and sets its target price to $170 from $190 previously.
On March 04, 2025, Citigroup Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $155 to $175.
Redburn Atlantic Upgraded its Sell to Neutral on March 03, 2025, while the target price for the stock was maintained at $188.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 20 ’25 when FOSTER JAMES C bought 6,075 shares for $165.01 per share. The transaction valued at 1,002,436 led to the insider holds 183,639 shares of the business.
Girshick Birgit bought 1,514 shares of CRL for $249,250 on Feb 20 ’25. The Corporate Executive VP & COO now owns 55,058 shares after completing the transaction at $164.63 per share. On Feb 20 ’25, another insider, LaPlume Joseph W, who serves as the EVP, Corp Strategy & Develop of the company, sold 4,400 shares for $162.50 each. As a result, the insider received 715,000 and left with 20,013 shares of the company.
Valuation Measures:
As of this moment, Charles’s Price-to-Earnings (P/E) ratio for their current fiscal year is 415.59, and their Forward P/E ratio for the next fiscal year is 10.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 161.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.29 while its Price-to-Book (P/B) ratio in mrq is 1.57.
Stock Price History:
Over the past 52 weeks, CRL has reached a high of $254.15, while it has fallen to a 52-week low of $91.86. The 50-Day Moving Average of the stock is -32.11%, while the 200-Day Moving Average is calculated to be -42.96%.
Shares Statistics:
A total of 51.14M shares are outstanding, with a floating share count of 48.56M. Insiders hold about 1.12% of the company’s shares, while institutions hold 109.33% stake in the company.
